Stephanie Shiau1, Sean S Brummel2, Elizabeth M Kennedy3, Karen Hermetz3, Stephen A Spector4,5, Paige L Williams2,6, Deborah Kacanek2, Renee Smith7, Stacy S Drury8, Allison Agwu9, Angela Ellis10, Kunjal Patel2,6, George R Seage6, Russell B Van Dyke11, Carmen J Marsit3. 1. Department of Biostatistics and Epidemiology, Rutgers School of Public Health, Piscataway, New Jersey. 2. Center for Biostatistics in AIDS Research, Harvard T.H. Chan School of Public Health, Boston, Massachusetts. 3. Gangarosa Department of Environ mental Health, Emory University Rollins School of Public Health, Atlanta, Georgia. 4. Department of Pediatrics, University of California, San Diego, La Jolla, California, USA. 5. Rady Children's Hospital, San Diego, California. 6. Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts. 7. Department of Pediatrics, University of Illinois at Chicago, Chicago, Illinois. 8. Department of Child and Adolescent Psychiatry, Tulane University School of Medicine, New Orleans, Louisiana. 9. Departments of Pediatric and Adult Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, Maryland. 10. Frontier Science & Technology, Amherst, New York. 11. Department of Pediatrics, Tulane School of Medicine, New Orleans, Louisiana, USA.
Abstract
OBJECTIVES: To quantify the rate of change in epigenetic age compared with chronological age over time in youth with perinatally acquired HIV (YPHIV) and youth who are perinatally HIV-exposed uninfected (YPHEU). DESIGN: Longitudinal study of 32 YPHIV and 8 YPHEU with blood samples collected at two time points at least 3 years apart. METHODS: DNA methylation was measured using the Illumina MethylationEPIC array and epigenetic age was calculated using the Horvath method. Linear mixed effects models were fit to estimate the average change in epigenetic age for a 1-year change in chronological age separately for YPHIV and YPHEU. RESULTS: Median age was 10.9 and 16.8 years at time 1 and 2, respectively. Groups were balanced by sex (51% male) and race (67% black). Epigenetic age increased by 1.23 years (95% CI 1.03--1.43) for YPHIV and 0.95 years (95% CI 0.74--1.17) for YPHEU per year increase in chronological age. Among YPHIV, in a model with chronological age, a higher area under the curve (AUC) viral load was associated with an increase in epigenetic age over time [2.19 years per log10 copies/ml, (95% CI 0.65--3.74)], whereas a higher time-averaged AUC CD4+ T-cell count was associated with a decrease in epigenetic age over time [-0.34 years per 100 cells/μl, (95% CI -0.63 to -0.06)] in YPHIV. CONCLUSION: We observed an increase in the rate of epigenetic aging over time in YPHIV, but not in YPHEU. In YPHIV, higher viral load and lower CD4+ T-cell count were associated with accelerated epigenetic aging, emphasizing the importance of early and sustained suppressive treatment for YPHIV, who will receive lifelong ART.
OBJECTIVES: To quantify the rate of change in epigenetic age compared with chronological age over time in youth with perinatally acquired HIV (YPHIV) and youth who are perinatally HIV-exposed uninfected (YPHEU). DESIGN: Longitudinal study of 32 YPHIV and 8 YPHEU with blood samples collected at two time points at least 3 years apart. METHODS: DNA methylation was measured using the Illumina MethylationEPIC array and epigenetic age was calculated using the Horvath method. Linear mixed effects models were fit to estimate the average change in epigenetic age for a 1-year change in chronological age separately for YPHIV and YPHEU. RESULTS: Median age was 10.9 and 16.8 years at time 1 and 2, respectively. Groups were balanced by sex (51% male) and race (67% black). Epigenetic age increased by 1.23 years (95% CI 1.03--1.43) for YPHIV and 0.95 years (95% CI 0.74--1.17) for YPHEU per year increase in chronological age. Among YPHIV, in a model with chronological age, a higher area under the curve (AUC) viral load was associated with an increase in epigenetic age over time [2.19 years per log10 copies/ml, (95% CI 0.65--3.74)], whereas a higher time-averaged AUC CD4+ T-cell count was associated with a decrease in epigenetic age over time [-0.34 years per 100 cells/μl, (95% CI -0.63 to -0.06)] in YPHIV. CONCLUSION: We observed an increase in the rate of epigenetic aging over time in YPHIV, but not in YPHEU. In YPHIV, higher viral load and lower CD4+ T-cell count were associated with accelerated epigenetic aging, emphasizing the importance of early and sustained suppressive treatment for YPHIV, who will receive lifelong ART.
Authors: Stephen R Cole; Sonia Napravnik; Michael J Mugavero; Bryan Lau; Joseph J Eron; Michael S Saag Journal: Am J Epidemiol Date: 2009-12-09 Impact factor: 4.897
Authors: Vardhman K Rakyan; Thomas A Down; Siarhei Maslau; Toby Andrew; Tsun-Po Yang; Huriya Beyan; Pamela Whittaker; Owen T McCann; Sarah Finer; Ana M Valdes; R David Leslie; Panogiotis Deloukas; Timothy D Spector Journal: Genome Res Date: 2010-03-10 Impact factor: 9.043
Authors: Riccardo E Marioni; Sonia Shah; Allan F McRae; Brian H Chen; Elena Colicino; Sarah E Harris; Jude Gibson; Anjali K Henders; Paul Redmond; Simon R Cox; Alison Pattie; Janie Corley; Lee Murphy; Nicholas G Martin; Grant W Montgomery; Andrew P Feinberg; M Daniele Fallin; Michael L Multhaup; Andrew E Jaffe; Roby Joehanes; Joel Schwartz; Allan C Just; Kathryn L Lunetta; Joanne M Murabito; John M Starr; Steve Horvath; Andrea A Baccarelli; Daniel Levy; Peter M Visscher; Naomi R Wray; Ian J Deary Journal: Genome Biol Date: 2015-01-30 Impact factor: 13.583
Authors: Brock C Christensen; E Andres Houseman; Carmen J Marsit; Shichun Zheng; Margaret R Wrensch; Joseph L Wiemels; Heather H Nelson; Margaret R Karagas; James F Padbury; Raphael Bueno; David J Sugarbaker; Ru-Fang Yeh; John K Wiencke; Karl T Kelsey Journal: PLoS Genet Date: 2009-08-14 Impact factor: 5.917
Authors: Eugene Andres Houseman; William P Accomando; Devin C Koestler; Brock C Christensen; Carmen J Marsit; Heather H Nelson; John K Wiencke; Karl T Kelsey Journal: BMC Bioinformatics Date: 2012-05-08 Impact factor: 3.169
Authors: Mary E Sehl; Elizabeth Crabb Breen; Roger Shih; Larry Chen; Ruibin Wang; Steve Horvath; Jay H Bream; Priya Duggal; Jeremy Martinson; Steven M Wolinsky; Otoniel Martinez-Maza; Christina M Ramirez; Beth D Jamieson Journal: Front Genet Date: 2022-02-28 Impact factor: 4.772
Authors: Elizabeth Crabb Breen; Mary E Sehl; Roger Shih; Peter Langfelder; Ruibin Wang; Steve Horvath; Jay H Bream; Priya Duggal; Jeremy Martinson; Steven M Wolinsky; Otoniel Martínez-Maza; Christina M Ramirez; Beth D Jamieson Journal: iScience Date: 2022-06-30